You May Also Like

FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
lenka29.02.2024

Synendos Therapeutics granted EMA clinical trial authorisation
lenka18.01.2024

William Pao joins Alentis Therapeutics as independent board member
lenka09.01.2024